EngineAI Raises Nearly RMB 1 Billion in Pre-A++ and A1 Rounds, Led by JD.com
A rising star in humanoid robotics, EngineAI drives innovation through cutting-edge technology, delivering intelligent, hyper-agile robots. Its proprietary joint modules set industry benchmarks for explosive power, torque, and rotational speed, enabling lifelike motion. By solving Sim2Real challenges, the company has carved out a unique tech advantage, achieving millimeter precision in high-dynamic maneuvers like complex dances, front flip, and sprinting.
The global humanoid robotics market is forecast to exceed $100 billion by 2030, driven by strong enterprise demand across manufacturing, services, and logistics. EngineAI's "open-source hardware + ecosystem profit-sharing" model accelerates market penetration through strategic partnerships, enabling rapid application diversification and developer engagement. To overcome embodied intelligence hurdles, the company merges traditional control systems with reinforcement learning, boosting efficiency, precision, and reliability. This dual approach not only truly meets market demands but also gradually penetrates into consumer households, forming a unique commercial ecosystem.
The newly secured capital will enable rapid advancement of EngineAI's core initiatives in H2 2025:
Product Development: EngineAI has built a comprehensive product matrix spanning bipedal and full humanoid robots across performance tiers. The company is now scaling trial production and delivery, targeting a 5x expansion of its production team to meet surging demand.
Technology Leadership: Embodied intelligence R&D will see intensified investment to fast-track core technology commercialization, solidifying EngineAI's global market position.
EngineAI has established strategic collaborations with industry giants including NVIDIA, Amazon, JD.com, Tencent, and ByteDance to advance humanoid robotics applications across commercial services, hazardous operations, and cultural tourism. These partnerships are accelerating the path to large-scale commercial adoption.
With production accelerating and certain production segments already exceeding capacity targets, EngineAI is on track to complete optimization upgrades ahead of Q4 2025. This expansion ensures reliable delivery of advanced robotic solutions, positioning the company for successful mass-market penetration.
EngineAI is expanding its workforce across critical R&D, production, and market expansion roles. The company is simultaneously enhancing its internal training programs to develop employees' technical and leadership capabilities, building a sustainable talent engine for continuous innovation.
Looking ahead, EngineAI will intensify efforts in mass production, product diversification, and embodied AI implementation, contributing core strengths to the high-quality development of the humanoid robotics industry.
For more information about EngineAI, please visit https://www.engineai.com.cn/.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Cision Canada
4 minutes ago
- Cision Canada
WuXi Biologics Launches HEK 293 Stable Cell Line Platform WuXia293 Stable for Development and Manufacturing of Difficult-to-Express Molecules
WuXia293 Stable platform demonstrates high titer, human glycosylation and improved product quality by eliminating or significantly alleviating truncation in difficult-to-express molecules. WuXia293 Stable platform maintains stable expression and consistent product quality during long-term cell passages, enabling scalable clinical and commercial manufacturing. SHANGHAI, Aug. 11, 2025 /CNW/ -- WuXi Biologics ( a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), today announced the launch of WuXia293 Stable, a new platform designed for the development and manufacturing of innovative, difficult-to-express molecules that are stably expressed in HEK293 cells. The platform, which demonstrates high titers, robust stability and superior quality, significantly enhances the developability and manufacturability of these molecules, offering a highly efficient CMC solution for biologics that are sophisticated in both structure and function. Conventionally, CHO cells have been widely utilized for recombinant protein expression with proven track record of high titers, and good developability and manufacturability. However, complex modalities may not be compatible with CHO expression system, resulting in low titer levels and truncation issues, due to the impact of some CHO-specific host cell proteins (HCPs), that compromise the quality and functionality of the protein products. In contrast, HEK293 cells can eliminate or significantly alleviate truncation issues in expressing complex molecules while maintaining high titer levels. WuXi Biologics developed WuXia293 Stable by leveraging its proprietary HEK293 cell line. Derived from WuXi Biologics' highly-vetted mammalian cell line development platform family WuXia™, WuXia293 Stable demonstrates productivity, quality and stability comparable to WuXia™ while maintaining full compatibility with its process, as shown by its robust growth and balanced metabolism. The platform achieves a fed-batch titer of up to 5.0 g/L for monoclonal antibodies while significantly improving purity. WuXia293 Stable offers flexible scalability in culture scale to meet the diverse needs of various research and pre-clinical development stages. Furthermore, the WuXia293 Stable cell line maintains stable expression and consistent quality during long-term cell passages, enabling scalable clinical and commercial manufacturing at 2000L scale for fed-batch and 1000L scale for perfusion. Moreover, WuXi Biologics offers a comprehensive suite of services for the WuXia293 Stable platform, including cell bank testing and viral clearance validation as part of its one-stop CMC solution. The launch of the WuXia293 Stable platform has further strengthened the service capabilities of WuXi Biologics' WuXia™ platform family. Besides WuXia293 stable, the WuXia™ platform has already derived multiple cell line development platforms, including WuXia ADCC Plus™ and WuXia RidGS™, to address customers' diverse requirements. Dr. Chris Chen, CEO of WuXi Biologics, commented, "We are excited to launch an industry-leading solution that significantly enhances the development of advanced therapeutics. WuXia293 Stable stands as a powerful testament to WuXi Biologics' unwavering commitment to our vision that every biologic can be made and exemplifies our dedication to technological innovation, which enables us to adeptly address the evolving needs of the biopharmaceutical industry. Once again we are reaffirming our promise to enable our clients in accelerating the delivery of innovative biologics to patients worldwide. " About the WuXia™ Cell Line Development Platform Family WuXia™ is a proven, high-yield (up to about 11 g/L) mammalian cell line platform family developed by WuXi Biologics. Accepted by regulatory agencies worldwide, the WuXia™ platform family have generated over 1000 cell lines expressing monoclonal and bispecific antibodies, fusion proteins, enzymes and other recombinant proteins for clinical and commercial manufacturing as of 2024. The WuXia™ platform family include WuXia ADCC Plus™ for developing and manufacturing afucosylated antibodies to elicit an enhanced ADCC response, WuXia RidGS™ for non-antibiotic cell line development, and the latest WuXia293 Stable for expressing difficult-to-express molecules built on HEK293 cell lines. The WuXia™ cell line development platform family continue to expand to cater to the diverse needs of global customers.
Cision Canada
4 minutes ago
- Cision Canada
Zoomlion's Corporate-Named Satellite Enters Orbit, Marking a New Era in Engineering Machinery with Digital, Intelligent, Green, and Global Vision
RIZHAO, China, Aug. 11, 2025 /CNW/ -- Zoomlion Heavy Industry Science & Technology Co., Ltd. ("Zoomlion," has reached a new milestone with the successful entry into orbit of the "Zoomlion" corporate-named satellite, the first of its kind in the global engineering machinery sector. At 00:31 Beijing time, the Geely Constellation Group 04 satellites were launched from the coastal waters near Rizhao, Shandong, China, using the Jielong-3 carrier rocket, with one satellite carrying the Zoomlion name. The "Zoomlion" satellite marks the company's expansion from construction sites on Earth to the vastness of space. It reflects Zoomlion's determination to accelerate digitalization, intelligence, sustainability, and global reach, ensuring service access in even the most challenging environments. As a leader in engineering machinery innovation, Zoomlion drives progress through eight national-level research platforms, over 17,800 patent applications, and more than 570 industry standards. Its groundbreaking products include China's first 3,000-ton crawler crane, the world's longest 101-meter carbon fiber boom pump truck, the first 10,000-ton-meter tower crane, the largest 4,000-ton all-terrain crane, and the highest 82-meter straight-arm aerial work platform. The satellite launch opens new possibilities for global service connectivity, from polar regions and deserts to offshore platforms. It also strengthens the integration of big data, IoT, AI, and satellite communications, supporting a next-generation service ecosystem capable of delivering smarter, faster, and greener solutions worldwide. With its Smart Industrial City as the core, Zoomlion operates 23 world-class intelligent factories, over 10 overseas R&D and manufacturing bases, and more than 30 primary logistics hubs, serving customers in over 200 countries and regions. The company will continue to explore frontier technologies and innovative applications to enhance service efficiency and customer value on a global scale. About Zoomlion Founded in 1992, Zoomlion Heavy Industry Science & Technology Co., Ltd. ( is a leading global manufacturer of high-end equipment, with core businesses in engineering machinery, mining machinery, and agricultural machinery. Its portfolio covers 15 major categories, 75 product series, and 745 product models. Operating in over 200 countries and regions, Zoomlion combines innovation, sustainability, and customer focus to drive progress and create a better future.
Cision Canada
4 hours ago
- Cision Canada
JBO Vietnam Announces Exclusive 2026 FIFA World Cup Bonuses - Up to 16.8M VND
, Aug. 11, 2025 /CNW/ -- With excitement growing for the 2026 FIFA World Cup, JBO Vietnam is proud to launch a limited-time promotion to make football more fun for fans across the country. This exclusive offer rewards both loyal players and new members, making every qualifying match more rewarding. JBO World Cup qualifiers promotion is available to all registered JBO Vietnam members who have selected Vietnamese Dong (VND) as their preferred currency. This special JBO promotion runs until 12 November 2025 and covers all 2026 World Cup qualifying matches, giving fans a chance to enjoy the action and earn great bonuses. Eligible users can participate through Inplay Matrix Sports, SABA Sports, and BTI Sports, stand a chance to earn up to 16,888,000 VND in bonus rewards based on your total accumulated betting turnover. Bonus credits will be issued by 22:59 (GMT+7) on the day following the end of each promotional phase. In addition, newly registered users are eligible for an exclusive welcome bonus of up to 5,000,000 VND, providing a valuable boost as they begin their World Cup journey with JBO. At JBO Vietnam, player safety is the highest priority. The platform uses strong security measures to keep all personal and financial information safe. With 24/7 customer support, players can get help anytime they need. With fast withdrawals and smooth gameplay, JBO is a great place for sports fans to enjoy matches and win real money. JBO proudly partners with football legend Dimitar Berbatov as its brand ambassador, strengthening its position as one of the top sportsbook platforms in Asia. The road to the 2026 World Cup is well underway. Register with JBO Vietnam today or download the JBO app to access exclusive promotions and be part of the action. About JBO Vietnam JBO (Just Bet Online) is a trusted online entertainment platform launched in 2019, serving players across Vietnam. It offers a wide variety of options, including sports, esports, slots, fishing games, and live casino experiences. With real-time action and high-quality gameplay, JBO continues to be a leading choice for sports fans, esports enthusiasts, and online gaming lovers in Vietnam.
